Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.02B | $2.13B | $2.19B | $2.20B | $1.79B | $2.42B | $2.38B | $2.32B | $2.33B | $2.44B |
| Revenue growth | — | 5.3% | 2.9% | 0.4% | -18.7% | 35.6% | -1.5% | -2.5% | 0.0% | 4.8% |
| Gross profit | $1.42B | $1.01B | $1.05B | $1.06B | $804M | $1.18B | $1.14B | $1.10B | $1.10B | $1.13B |
| Gross margin | 70.1% | 47.5% | 47.8% | 48.4% | 45.0% | 48.8% | 47.6% | 47.3% | 47.2% | 46.3% |
| Operating income | $108M | $74.4M | $81.8M | $83.3M | -$107M | $156M | $93.2M | -$13.5M | $13.9M | $17.3M |
| Operating margin | 5.3% | 3.5% | 3.7% | 3.8% | -6.0% | 6.4% | 3.9% | -0.6% | 0.6% | 0.7% |
| Net income | $97.4M | -$112M | -$51.9M | $61.4M | -$56.4M | $115M | $71.9M | -$16.8M | -$18.9M | $13.3M |
| Net margin | 4.8% | -5.3% | -2.4% | 2.8% | -3.2% | 4.7% | 3.0% | -0.7% | -0.8% | 0.5% |
| EPS (diluted) | $4.83 | -$5.80 | -$2.66 | $3.92 | -$3.97 | $7.92 | $5.66 | -$1.50 | -$1.74 | $1.25 |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $165M | $165M | $237M | $117M | $158M | $240M | -$165M | $94.8M | $87.9M | $146M |
| Capital expenditures | $94.0M | $128M | $57.2M | $29.8M | $24.1M | $53.9M | $59.9M | $60.3M | $41.1M | $62.1M |
| Free cash flow | $71.3M | $36.7M | $180M | $87.4M | $134M | $186M | -$225M | $34.5M | $46.8M | $83.7M |
| Share buybacks | $140M | $16.2M | $44.9M | $190M | $0.00 | $78.1M | $77.5M | $32.0M | $9.79M | $12.6M |
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $48.3M | $39.9M | $167M | $81.4M | $215M | $321M | $48.0M | $35.2M | $34.0M | $105M |
| Total assets | $1.44B | $1.32B | $1.18B | $1.68B | $1.59B | $1.56B | $1.46B | $1.33B | $1.34B | $1.39B |
| Total liabilities | $518M | $485M | $444M | $1.06B | $1.02B | $960M | $849M | $759M | $789M | $826M |
| Long-term debt | $73.7M | $86.6M | $56.8M | $14.4M | $33.0M | $15.7M | $44.9M | $34.7M | $0.00 | $3.38M |
| Shareholders' equity | $921M | $831M | $738M | $619M | $567M | $602M | $607M | $571M | $547M | $567M |
| Retained earnings | $731M | $604M | $509M | $379M | $321M | $350M | $347M | $297M | $266M | $266M |
| Shares (wtd avg diluted) | 20.2M | 19.3M | 19.5M | 15.7M | 14.2M | 14.5M | 12.7M | 11.2M | 10.8M | 10.6M |
Every figure is extracted from GENESCO INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.